Organogenesis Holdings Inc. Stock Analysis & AI Score
Organogenesis Holdings Inc. (ORGO) has an ST Score of 42.5 (C), driven by its Financial Strength (A-) and held back by its Momentum (D-). Analysts rate it Buy with a $2.50 price target (+76.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Organogenesis Holdings Inc. (ORGO) has an ST Score of 42.5 (C), driven by its Financial Strength (A-) and held back by its Momentum (D-). Analysts rate it Buy with a $2.50 price target (+76.1% upside).
- Strongest
- Financial StrengthA-
- Weakest
- MomentumD-
All factor grades
- Financial StrengthA-
- ForecastB+
- ValuationB
- GrowthC+
- ProfitabilityD
- MomentumD-
- Piotroski2/9
Contact
ORGO stock: frequently asked questions
What is ORGO's ST Score?
Organogenesis Holdings Inc. (ORGO) has an ST Score of 42.5 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ORGO a buy, hold, or sell?
Analysts rate ORGO a Buy, with a price target of $2.50 (+76.1% vs the current price). Our ST Score grades it C (42.5/100). The ST Score is a data-driven signal, not a recommendation.
What are ORGO's factor grades?
Valuation B, Profitability D, Financial Strength A-, Momentum D-, Growth C+, Forecast B+.
What is ORGO's valuation grade?
Organogenesis Holdings Inc. (ORGO) earns a valuation grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ORGO's growth grade?
Organogenesis Holdings Inc. (ORGO) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ORGO's profitability grade?
Organogenesis Holdings Inc. (ORGO) earns a profitability grade of D, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ORGO's financial strength grade?
Organogenesis Holdings Inc. (ORGO) earns a financial strength grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ORGO?
The average analyst price target for Organogenesis Holdings Inc. (ORGO) is $2.50 from 6 analysts, which is +76.1% versus the recent price of $1.42.
What is ORGO's Piotroski score?
Organogenesis Holdings Inc. (ORGO) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.